Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Strategy for the Next few Months
View:
Post by Scorpio2 on Nov 30, 2022 2:42pm

Strategy for the Next few Months

I would suggest to all to best utilize the the next few months as follows:

1) take gains out of your TFSA a/c in stock you hold (other than TLT shares) in the 2022 tax year.
2) transfer those proceeds to your bank account. Spend that money or recontribute that amount to your margin a/c.
3) if you currently have TLT stock in your margin a/c, do a specie "in kind" transfer of TLT stock from your margin account to your TFSA a/c in the 2023 tax year in the same amount as what was withdrawn in 2022. You are allowed to do this in the following year after the withdrawl year.
4) in the new 2023 tax year, also transfer in the allowable cash contribution to your TFSA a/c and buy TLT stock or again do a specie "in kind" transfer of TLT shares from your margin a/c to your TFSA a/c based upon the price on the day you execute this transaction in 2023.

This will probably be your last chance to move and protect as many TLT shares as possible in your (tax exempt) TFSA a/c. Once BTD/AA application is made (likely mid to end of December 2022), the FDA will respond to Theralase in 60 days (say mid Feb 2023) on whether or not BTD/AA is granted. If granted, TLT stock goes parabolic. Pharmas circle. Any capital gains on a takeout/JV/etc will be protected from taxation in your  TFSA. Then enjoy the rest of your life !!!!
Comment by Legit62 on Nov 30, 2022 3:21pm
I have a strong suspician they may wait till Roger is in the captains chair until the big news arrives, this is his baby, i think Feb, with all his recent share activity
Comment by CAinPlap on Dec 01, 2022 10:12am
Why wouldn't you just buy TLT in 2022 from the proceeds of other stock sales? Waiting until 2023 could cost more per share. No need to transfer to bank account and transfer back in new year. Unless you like paying transfer fees?
Comment by Scorpio2 on Dec 01, 2022 10:48am
CainPlap,to answer your questions, I'm maxed out on my total allocation to TLT in terms of # of shares and don't want to buy any more in any of my accounts. Also, I hold a lot of shares in my margin account which I can now transfer in large quantities (at one price) to my TFSA in 2023 due to my TFSA sales in 2022. If I were just to buy the TLT shares in my TFSA now, I would end up pushing ...more  
Comment by CAinPlap on Dec 01, 2022 12:40pm
You said in your original post to sell existing stocks and transfer the proceeds to your bank account and then transfer back to TFSA in new year. Why not just leave the proceeds in your TFSA in the 1st place regardless of whether used to buy TLT? 
Comment by Scorpio2 on Dec 01, 2022 2:35pm
CainPlap....I don't think you are cluing into what I'm doing. By taking cash (a lot) out of my TFSA as a withdrawl in 2022, I can then replace the withdrawn amount in early 2023 with a specie transfer (a lot) of TLT stock from my margin account in a $ amount equal to my earlier $ withdrawl. This way I can move (a lot of) TLT shares in one transaction from a margin account to my TFSA ...more  
Comment by CAinPlap on Dec 01, 2022 4:39pm
I get your point but depending on your cost base in your margin account you may either incur capital gains or restricted capital loss on the transfer. You would have to have a lot of TFSA room to affect the stockprice on an openmarket buy IMO. Not saying you haven't presented a decent argument for your strategy but it may have unintended consequences you haven't considered.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250